Science

#Risk factors ID’d for VTE, ASCVD in rheumatoid arthritis patients

#Risk factors ID’d for VTE, ASCVD in rheumatoid arthritis patients

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is increased after unprovoked VTE, according to a study recently published in RMD Open.

Gulsen Ozen, M.D., from the University of Nebraska Medical Center in Omaha, and colleagues compared risk factors for VTE and ASCVD among patients with RA participating in a U.S.-wide longitudinal observational registry. The subsequent risk for ASCVD after an unprovoked VTE was assessed.

The researchers identified 539 unprovoked VTE and 1,648 ASCVD events during a median four years of follow-up in 31,366 patients with RA. In adjusted models, increased VTE and ASCVD risk were seen with older age, male sex, comorbidities, prior fracture, worse disability, and higher disease activity. In both patients with ASCVD and VTE, traditional cardiovascular disease risk factors were common, but they only increased ASCVD risk, with the exception of obesity, which was associated with an increased risk for VTE (hazard ratio, 1.46). After unprovoked VTE, the risk for ASCVD was increased twofold (hazard ratio, 2.05).

“Patients with RA with an unprovoked VTE had a doubled risk of developing an ASCVD,” the authors write. “Our findings support that unprovoked VTE may be a spectrum of pan-cardiovascular syndrome in patients with RA and a risk factor for a future ASCVD.”


Gender disparities seen in care for younger patients with ASCVD


More information:
Abstract/Full Text

Copyright © 2021 HealthDay. All rights reserved.

Citation:
Risk factors ID’d for VTE, ASCVD in rheumatoid arthritis patients (2021, July 23)
retrieved 24 July 2021
from https://medicalxpress.com/news/2021-07-factors-idd-vte-ascvd-rheumatoid.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.

For forums sites go to Forum.BuradaBiliyorum.Com

If you want to read more Like this articles, you can visit our Science category.

Source

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Please allow ads on our site

Please consider supporting us by disabling your ad blocker!